Technical Analysis for VBLT - Vascular Biogenics Ltd.

Grade Last Price % Change Price Change
grade C 1.43 1.42% 0.02
VBLT closed up 1.42 percent on Friday, January 17, 2020, on 1.52 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical VBLT trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Calm After Storm Range Contraction 1.42%
Narrow Range Bar Range Contraction 1.42%
NR7 Range Contraction 1.42%
Upper Bollinger Band Walk Strength 1.42%
Inside Day Range Contraction 1.42%
Wide Bands Range Expansion 1.42%
Overbought Stochastic Strength 1.42%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates include VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, as well as VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Or Yehuda, Israel.
Medicine Biotechnology Health Biopharmaceutical Cancer Medical Specialties Pharmaceutical Industry Autoimmune Diseases Clinical Trial Ovarian Cancer Psoriasis Ulcerative Colitis Treatment Of Ovarian Cancer Brain Cancer Recurrent Glioblastoma Thyroid Cancer

Is VBLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1.9
52 Week Low 0.93
Average Volume 85,894
200-Day Moving Average 1.27
50-Day Moving Average 1.23
20-Day Moving Average 1.26
10-Day Moving Average 1.36
Average True Range 0.08
ADX 31.72
+DI 29.01
-DI 10.79
Chandelier Exit (Long, 3 ATRs ) 1.26
Chandelier Exit (Short, 3 ATRs ) 1.16
Upper Bollinger Band 1.49
Lower Bollinger Band 1.03
Percent B (%b) 0.87
BandWidth 36.35
MACD Line 0.06
MACD Signal Line 0.04
MACD Histogram 0.0224
Fundamentals Value
Market Cap 38.62 Million
Num Shares 27 Million
EPS -0.67
Price-to-Earnings (P/E) Ratio -2.13
Price-to-Sales 0.00
Price-to-Book 4.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.52
Resistance 3 (R3) 1.52 1.48 1.51
Resistance 2 (R2) 1.48 1.46 1.49 1.50
Resistance 1 (R1) 1.46 1.45 1.47 1.46 1.49
Pivot Point 1.42 1.42 1.43 1.43 1.42
Support 1 (S1) 1.40 1.40 1.41 1.40 1.37
Support 2 (S2) 1.36 1.39 1.37 1.36
Support 3 (S3) 1.34 1.36 1.36
Support 4 (S4) 1.34